Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

HOPA 2018 | Treating GvHD: current challenges and newly approved drugs

Katie Gatwood • 21 Mar 2018
HOPA 2018
General Ibrutinib Ruxolitinib

Graft versus host disease (GvHD) remains to be one of the leading causes of morbidity and mortality in patients who have undergone bone marrow transplant. Here, Katie Gatwood, PharmD, BCOP, of Vanderbilt University Medical Center, Nashville, TN, briefly discusses the challenges with current treatment options for GvHD and gives an update on newly approved drugs that can be used to effectively treat patients. This interview was recorded at the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO.

More from Katie Gatwood

The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib
1:43
The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib
Katie Gatwood • 21 Mar 2018
Ruxolitinib and ibrutinib: the future for GvHD treatment?
2:29
Ruxolitinib and ibrutinib: the future for GvHD treatment?
Katie Gatwood • 21 Mar 2018

Related Videos

Combining isatuximab, lenalidomide, oral cyclophosphamide, & dexamethasone for HR smoldering myeloma
4:53
Combining isatuximab, lenalidomide, oral cyclophosphamide, & dexamethasone for HR smoldering myeloma
Maher Salamoon • 9 Sep 2026
Treating peripheral T-cell lymphoma with chemotherapy, avelumab and brentuximab vedotin
4:17
Treating peripheral T-cell lymphoma with chemotherapy, avelumab and brentuximab vedotin
Maher Salamoon • 9 Sep 2026
Insights into the risk of pulmonary infections in patients with CLL treated with targeted agents
5:31
Insights into the risk of pulmonary infections in patients with CLL treated with targeted agents
Maher Salamoon • 8 Sep 2026
Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals